Nikki Bailes
Family · Gettysburg, PANPI 1639473713
Payments from drug & device makers
Across 147 payments — averaging $17.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$543
- Abbott$506
- AbbVie$294
- Dexcom, Inc.$244
- Insulet Corporation$150
- Amgen$135
- plus $713 from 18 others
What the payments were for
- Food & beverage$2,585100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 40 | $543 |
| Abbott | 25 | $506 |
| AbbVie | 16 | $294 |
| Dexcom, Inc. | 14 | $244 |
| Insulet Corporation | 7 | $150 |
| Amgen | 8 | $135 |
| Tandem Diabetes Care, Inc. | 7 | $118 |
| AstraZeneca | 4 | $67 |
| Boehringer Ingelheim | 4 | $64 |
| Mylan Specialty L.p. | 3 | $64 |
| Lilly USA, LLC | 3 | $60 |
| Medtronic | 2 | $54 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $48 |
| Nestle Healthcare Nutrition Inc. | 1 | $32 |
| Rhythm Pharmaceuticals, Inc. | 1 | $27 |
| Pfizer | 1 | $25 |
| Ascensia Diabetes Care US Inc. | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Astellas Pharma US Inc | 1 | $21 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| Novartis | 1 | $20 |
| GSK | 1 | $19 |
| Exact Sciences | 1 | $15 |
| Amarin Pharma, Inc. | 1 | $14 |
How this compares
$2,585 in reported general payments places this provider in the 85th percentile of 4,717 family providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 393 | $500,442 |
| OzempicSemaglutide | 210 | $273,983 |
| Tresiba Flextouch U-200Insulin Degludec | 89 | $145,186 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 96 | $129,195 |
| JardianceEmpagliflozin | 95 | $97,708 |
| FarxigaDapagliflozin Propanediol | 64 | $81,417 |
| JanuviaSitagliptin Phosphate | 68 | $72,675 |
| Novolog FlexpenInsulin Aspart | 174 | $61,073 |
| Humulin R U-500 KwikpenInsulin Regular, Human | 31 | $57,857 |
| Tresiba Flextouch U-100Insulin Degludec | 82 | $54,867 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 67 | $52,389 |
| TradjentaLinagliptin | 37 | $43,246 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 15 | $22,153 |
| RybelsusSemaglutide | 19 | $21,640 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 84 | $19,230 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity, Humalog | $60 | $519,019418 claims |
| Novo NordiskOzempic, Rybelsus, Novolog | $543 | $307,630275 claims |
| Boehringer IngelheimJardiance, Tradjenta | $64 | $140,954132 claims |
| AstraZenecaFarxiga | $67 | $81,41764 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,717 family providers in Pennsylvania.
Other family in Gettysburg
- Kathleen ScholzPittsburgh$397K
- Shannon FitzgeraldAllison Park$370K
- Stephanie HarshbargerCamp Hill$317K
- Whitney BowlesFort Washington$253K
- Kweilynn GreenePittsburgh$139K
- Jessica LindenbergerPittsburgh$131K
- Kami NestlerWilkes Barre$129K
- Bethany ThomasPhiladelphia$126K
- Margaret RosenzweigPittsburgh$89K
- Amanda GrippoDickson Cty$86K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.